NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ALC

Alcon Inc

Jul 02 • 04:00PM ET

89.30

Dollar change +0.28
Percentage change 0.31	%

Healthcare • Medical Instruments & Supplies • Switzerland • NYSE

Peers: JNJ ABT MDT SYK ISRG ZBH BDX BAX BSX COO

| Held by: DFIV DFAI DFIC DFAX RUNN TOUS AGNG CACG FIVA DFSI

Scroll to Statements

Index	-	P/E	39.69	EPS (ttm)	2.25	Insider Own	1.07%	Shs Outstand	495.70M	Perf Week	1.98%
Market Cap	44.17B	Forward P/E	24.60	EPS next Y	3.63	Insider Trans	0.00%	Shs Float	489.33M	Perf Month	4.85%
Enterprise Value	47.98B	PEG	3.77	EPS next Q	0.72	Inst Own	55.90%	Short Float	0.97%	Perf Quarter	-3.67%
Income	1.12B	P/S	4.45	EPS this Y	2.42%	Inst Trans	-0.75%	Short Ratio	2.77	Perf Half Y	4.26%
Sales	9.93B	P/B	2.01	EPS next Y	16.21%	ROA	3.70%	Short Interest	4.73M	Perf YTD	5.19%
Book/sh	44.39	P/C	31.28	EPS next 5Y	10.52%	ROE	5.23%	52W High	101.10 -11.67%	Perf Year	0.25%
Cash/sh	2.85	P/FCF	26.72	EPS past 3/5Y	38.96% -	ROIC	4.14%	52W Low	80.48 10.96%	Perf 3Y	28.64%
Dividend Est.	0.33 (0.37%)	EV/EBITDA	17.34	Sales past 3/5Y	6.13% 5.71%	Gross Margin	55.55%	Volatility	1.38% 1.34%	Perf 5Y	54.63%
Dividend TTM	0.66 (0.74%)	EV/Sales	4.83	EPS Y/Y TTM	6.56%	Oper. Margin	15.39%	ATR (14)	1.46	Perf 10Y	-
Dividend Ex-Date	May 14, 2025	Quick Ratio	1.66	Sales Y/Y TTM	3.80%	Profit Margin	11.28%	RSI (14)	57.48	Recom	1.63
Dividend Gr. 3/5Y	13.30% -	Current Ratio	2.70	EPS Q/Q	40.73%	SMA20	2.41%	Beta	0.95	Target Price	106.55
Payout	15.44%	Debt/Eq	0.24	Sales Q/Q	0.57%	SMA50	-0.57%	Rel Volume	0.72	Prev Close	89.02
Employees	25599	LT Debt/Eq	0.23	Earnings	May 14 BMO	SMA200	-1.19%	Avg Volume	1.70M	Price	89.30
IPO	Apr 09, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.16% -2.39%	Trades		Volume	1,221,323	Change	0.31%

Date	Action	Analyst	Rating Change	Price Target Change
May-20-25	Downgrade	Deutsche Bank	Buy → Hold
May-14-25	Reiterated	BTIG Research	Buy	$102 → $99
Mar-28-25	Reiterated	Needham	Buy	$107 → $110
Mar-25-25	Upgrade	BofA Securities	Neutral → Buy
Jan-24-25	Reiterated	Needham	Buy	$108 → $106
Jan-10-25	Upgrade	Redburn Atlantic	Neutral → Buy
Dec-17-24	Reiterated	Needham	Buy	$103 → $108
Nov-12-24	Reiterated	Needham	Buy
Oct-10-24	Upgrade	Redburn Atlantic	Sell → Neutral
Sep-10-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jul-15-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$65 → $85
May-15-24	Upgrade	Oppenheimer	Perform → Outperform	$103
Apr-10-24	Initiated	Goldman	Buy	$100
Mar-14-24	Initiated	RBC Capital Mkts	Sector Perform
Feb-06-24	Resumed	KeyBanc Capital Markets	Overweight	$87
Jan-23-24	Initiated	Bernstein	Outperform	$94.40
Dec-18-23	Downgrade	Redburn Atlantic	Neutral → Sell
Dec-12-23	Initiated	Stifel	Buy	$85
Dec-04-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$85 → $65
Aug-17-23	Upgrade	JP Morgan	Neutral → Overweight	$79.80 → $89.30

Show Previous Ratings

Jul-02-25 08:17AM	Is it Apt to Retain Alcon Stock in Your Portfolio for Now? (Zacks)
Jun-26-25 09:03AM	Alcon Canada Earns Global Recognition as a Top Employer (Business Wire)
Jun-20-25 09:02AM	Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL (Business Wire)
Jun-02-25 08:43AM	COO Q2 Earnings Signal Growth and Caution: How to Play the Stock? (Zacks)
May-30-25 07:50AM	US FDA approves Alcon's Tryptyr ophthalmic solution for Dry Eye Disease (Pharmaceutical Business Review)
09:31AM	Loading…
May-29-25 09:31AM	Alcon Stock Rises Following the FDA Approval of TRYPTYR (Zacks)
May-28-25 11:58PM	Alcon Inc. (ALC)'s TRYPTYR Wins FDA Nod for Dry Eye Disease (Insider Monkey)
04:40PM	Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease (Business Wire)
May-15-25 09:42AM	Company News for May 15, 2025 (Zacks)
May-14-25 07:22PM	Analyst Report: Alcon Inc. (Morningstar Research) -6.45%
08:49AM	Alcon Q1 Earnings Miss Estimates, Stock Down, 2025 EPS View Lowered (Zacks)
May-13-25 06:00PM	Alcon (ALC) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
04:30PM	Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS (Business Wire)
May-12-25 07:00PM	April CPI, On Holding earnings, NFIB optimism: What to Watch (Yahoo Finance Video)
04:18PM	Top Research Reports for Texas Instruments, Boeing & NextEra Energy (Zacks)
05:00AM	Loading…
May-11-25 05:00AM	What To Expect in the Markets This Week (Investopedia)
May-08-25 09:15AM	Ahead of Alcon (ALC) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
May-06-25 04:30PM	Alcon Announces Results of 2025 Annual General Meeting (Business Wire)
May-01-25 03:54PM	ClearBridge Large Cap Growth ESG Portfolios Q1 2025 Commentary (Seeking Alpha)
10:14AM	Do Options Traders Know Something About Alcon Stock We Don't? (Zacks)
Apr-30-25 07:27PM	Analyst Report: Alcon Inc. (Morningstar Research)
Apr-28-25 06:34AM	ClearBridge Large Cap Growth Portfolios Q1 2025 Commentary (Seeking Alpha)
Apr-27-25 11:02PM	ClearBridge Large Cap Growth Fund Q1 2025 Commentary (Seeking Alpha)
Apr-25-25 08:00AM	Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS (Business Wire)
Apr-16-25 11:09AM	3 Stocks Upping Dividends & 1 With A 10% Special Dividend Yield (MarketBeat)
Apr-13-25 04:19PM	ClearBridge Large Cap Growth ESG Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-11-25 10:10AM	Harding Loevner International Equity Q1 2025 Commentary (Seeking Alpha)
Apr-10-25 01:59PM	Alcon: A Clear Vision, But Fully Valued (Seeking Alpha)
Apr-09-25 06:33AM	ClearBridge International Growth EAFE Strategy Q1 2025 Commentary (Seeking Alpha) +8.58%
Apr-08-25 10:45AM	Here's Why ClearBridge Large Cap Growth Strategy Sold Alcon (ALC) (Insider Monkey)
06:15AM	Loading…
Apr-07-25 06:15AM	ClearBridge Large Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-04-25 01:00AM	Alcon Publishes Agenda for 2025 Annual General Meeting (Business Wire) -6.46%
Apr-03-25 06:51PM	Analyst Report: Alcon Inc. (Morningstar Research)
07:56AM	ALC Stock May Rise With the Introduction of PanOptix Pro in US (Zacks)
Apr-02-25 08:00AM	Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter (Business Wire)
Apr-01-25 10:49AM	The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals (Zacks)
01:03AM	Impax Global Opportunities Fund Q4 2024 Commentary (Seeking Alpha)
Mar-31-25 09:10AM	3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space (Zacks)
Mar-28-25 11:30AM	Avanos Medical (AVNS) Down 5.8% Since Last Earnings Report: Can It Rebound? (Zacks)
07:28AM	Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock? (Zacks)
Mar-27-25 04:34PM	Analyst Report: Alcon Inc. (Morningstar Research) +6.00%
Mar-26-25 11:10PM	Franklin International Growth Fund Q4 2024 Commentary (SeekingAlpha)
04:30PM	Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease (Business Wire)
Mar-25-25 03:10PM	Alcon Stock Sees RS Rating Climb To 74 (Investor's Business Daily)
09:00AM	Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit (TipRanks)
08:44AM	Alcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark Approval (Zacks)
08:35AM	ALC Stock Rises Following the Merger Agreement With LENSAR (Zacks)
01:00AM	Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities (Business Wire)
Mar-24-25 08:00AM	Alcon Agrees to Acquire LENSAR, Inc. (GlobeNewswire)
Mar-13-25 09:02AM	Alcon to Host 2025 Capital Markets Day (Business Wire)
Mar-04-25 03:04PM	Alcon Stock Gets Relative Strength Rating Lift (Investor's Business Daily)
Feb-27-25 09:02AM	Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters (Business Wire)
Feb-26-25 03:20PM	Analyst Report: Alcon Inc. (Morningstar Research)
Feb-25-25 04:30PM	Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation (Business Wire)
Feb-24-25 08:02AM	Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet (Business Wire)
Feb-19-25 08:02AM	Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension (Business Wire)
Dec-31-24 04:30PM	Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-13-24 01:25PM	Analyst Report: Alcon Inc. (Morningstar Research)
Nov-12-24 12:09PM	Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation (Business Wire) -5.84%
Nov-07-24 01:00AM	Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh (Business Wire)
Oct-27-24 09:00PM	Alcon Singapore Elevates Associate Experience with Inspiring Engagement Programs (Business Wire)
Oct-15-24 09:03AM	Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance (Business Wire)
Sep-05-24 07:54PM	Jim Cramer Says It Will Take Time For Novartis AG (NVS) To Get The Attention Of Investors' (Insider Monkey)
Sep-04-24 03:29PM	Top 10 Stocks on Jim Cramer's Radar (Insider Monkey)
Aug-27-24 06:42PM	Alcon Inc. (ALC): One of Oppenheimer's Top Stock Picks For the Next 12 Months (Insider Monkey)
Aug-21-24 04:22PM	Analyst Report: Alcon Inc. (Morningstar Research)
04:52AM	Alcon shares drop on earnings miss (Investing.com)
Aug-20-24 06:00PM	Alcon (ALC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:30PM	Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses (Business Wire)
Jul-16-24 02:35AM	Here's Why Aristotle Capital's International Equity Composite Sold Novartis AG (NVS) (Insider Monkey)
Jul-15-24 11:07AM	Alcon (ALC) Rides on Innovation, Balanced Segmental Sales (Zacks)
Jul-05-24 09:00AM	Alcon (ALC) Inks Buyout Deal to Expand Its Glaucoma Portfolio (Zacks)
Jun-25-24 10:01AM	Are Options Traders Betting on a Big Move in Alcon (ALC) Stock? (Zacks)
Jun-24-24 09:37AM	Alcon (ALC) Achieves FDA 510(k) Clearance for Unity VCS and Unity CS (Zacks)
01:00AM	Alcons Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance (Business Wire)
Jun-10-24 09:50AM	Why Alcon (ALC) is a Top Momentum Stock for the Long-Term (Zacks)
May-30-24 04:00AM	Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board (GlobeNewswire)
May-24-24 09:53AM	Reasons to Include Alcon (ALC) in Your Portfolio Right Now (Zacks)
May-23-24 09:40AM	Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year? (Zacks)
08:40AM	Do Options Traders Know Something About Alcon (ALC) Stock We Don't? (Zacks)
May-20-24 10:53AM	ALC Stock Earnings: Alcon Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-15-24 08:18AM	Alcon Inc. (NYSE:ALC) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-14-24 05:03PM	Health Care Roundup: Market Talk (The Wall Street Journal) +10.33%
04:31PM	Analyst Report: Alcon Inc. (Morningstar Research)
12:55PM	Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand (Zacks)
May-13-24 04:30PM	Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health (Business Wire)
May-10-24 08:52AM	Why Alcon (ALC) Might Surprise This Earnings Season (Zacks)
May-08-24 04:30PM	Alcon Announces Results of 2024 Annual General Meeting (Business Wire)
Apr-18-24 08:49AM	15 Best Low Cost ETFs (Insider Monkey)
Apr-07-24 05:59PM	Alcon Publishes Agenda for 2024 Annual General Meeting (Business Wire)
Apr-03-24 09:51AM	Here's Why Investors Should Buy Alcon (ALC) Stock Right Now (Zacks)
Mar-29-24 05:02PM	15 Biggest Swiss Companies (Insider Monkey)
Mar-14-24 11:37AM	Analyst Report: Alcon Inc. (Morningstar Research)
Mar-13-24 08:34AM	Alcon's (ALC) New Launch Strengthens IOL Innovation Leadership (Zacks)
Mar-12-24 04:30AM	Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India (Business Wire)
Mar-08-24 02:53PM	Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:31AM	Alcon's (ALC) Vivity EDOF IOL Achieves One Million Milestone (Zacks)
Mar-06-24 09:55AM	Vivity, the Worlds Leading EDOF IOL, Reaches One Million Milestone (Business Wire)
Feb-29-24 04:19AM	20 Countries With Worst Vision Problems (Insider Monkey)
Feb-28-24 03:39PM	Analyst Report: Alcon Inc. (Morningstar Research) +5.56%

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Duplan Sergio	Officer	Mar 03 '25	Proposed Sale	93.20	12,600	1,174,320	Mar 03 01:04 PM
STONESIFER TIMOTHY C.	Officer	Feb 28 '25	Proposed Sale	92.09	20,000	1,841,800	Feb 28 02:49 PM
Attias Laurent	Officer	Feb 27 '25	Proposed Sale	91.88	9,000	826,920	Feb 27 10:56 AM
Endicott David J.	Officer	Sep 12 '24	Proposed Sale	100.49	112,182	11,273,015	Sep 12 05:34 PM
Bell Ian	Officer	Sep 12 '24	Proposed Sale	100.00	10,000	1,000,047	Sep 12 03:53 PM
Narayanan Rajkumar	Officer	Sep 09 '24	Proposed Sale	96.54	4,622	446,208	Sep 09 02:04 PM
Duplan Sergio	Officer	Aug 22 '24	Proposed Sale	95.90	2,000	191,802	Aug 22 11:27 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ALC

Alcon Inc

Upgrade your FINVIZ experience